PFE250117C32000
- 0.01
- 0.000.00%
Pfizer Newsroom
Pfizer Is Maintained at Neutral by Citigroup
Citi Maintains Pfizer(PFE.US) With Hold Rating, Announces Target Price $29
Pfizer Analyst Ratings
Pfizer Plans To Present Latest Results From Its Genitourinary Portfolio At ASCO GU Cancers Symposium Taking Place February 13-15 In San Francisco, California
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
Express News | Pfizer to Showcase Advancements Across Genitourinary Cancers at Asco Gu Cancers Symposium
Express News | Pfizer : Citigroup Cuts Target Price to $29 From $30
Drug Companies Raise Prices on More Than 800 Drugs in January -- WSJ
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
Pfizer Options Spot-On: On January 27th, 219.47K Contracts Were Traded, With 2.82 Million Open Interest
On January 27th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 219.47K options for the day, of which put options accounted for 26.07% of the total transactions, and
Pfizer Gains After Activist Investor Forgoes Board Nominations
Sector Update: Health Care
Pfizer Shares Are Trading Higher. The Stock May Be Higher Amid Activist Starboard Value's Decision to Not Pursue a Proxy Battle With the Company.
Market Chatter: Pfizer Seen Getting Respite From Battle With Activist Investor Starboard
10 Health Care Stocks With Whale Alerts In Today's Session
Intellia Downgraded at Morgan Stanley on Lowered Expectations for Rare Disease Asset
Lucia and Heart Rhythm Society Announce Strategic Collaboration to Enhance UpBeat.org for AFib Patients, Sponsored by the BMS-Pfizer Alliance
Express News | No Proxy Fight for Pfizer From Starboard- CNBC
Pfizer Reports Positive Outcomes From Trial of MCRC Combination Therapy
Pfizer to Pay $59.7 Million to Resolve Biohaven's Alleged Kickback Scheme for Nurtec ODT